A Multiple Ascending Dose Study of ETC-1002 in Healthy Subjects

NCT01485146 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety Evaluation of Escalating Doses

Interventions

DRUG: ETC-1002

Sponsor

Esperion Therapeutics, Inc.